(Q43048609)

English

Interferon‐Ribavirin in Association with Stavudine Has No Impact on Plasma Human Immunodeficiency Virus (HIV) Type 1 Level in Patients Coinfected with HIV and Hepatitis C Virus: A CORIST‐ANRS HC1 Trial

scientific article published on May 9, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Interferon-ribavirin in association with stavudine has no impact on plasma human immunodeficiency virus (HIV) type 1 level in patients coinfected with HIV and hepatitis C virus: a CORIST-ANRS HC1 trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Interferon‐Ribavirin in Association with Stavudine Has No Impact on Plasma Human Immunodeficiency Virus (HIV) Type 1 Level in Patients Coinfected with HIV and Hepatitis C Virus: A CORIST‐ANRS HC1 Trial (English)

1 reference

https://api.crossref.org/works/10.1086/374837

2 January 2024

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Hepatitis C virus

1 reference

based on heuristic

inferred from title

Geneviève Chêne

14

object named as

Geneviève Chêne

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Magali Bouvier-Alias

5

object named as

Magali Bouvier-Alias

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Cécile Goujard

7

object named as

Cécile Goujard

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

3

object named as

Alain Pruvost

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12746776

2 January 2024

4

object named as

Henri Benech

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12746776

2 January 2024

9

object named as

Fabien Zoulim

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12746776

2 January 2024

author name string

Dominique Salmon-Céron

1

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Régis Lassalle

2

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Christopher Payan

6

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Eric Bonnet

8

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Philippe Morlat

10

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Philippe Sogni

11

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Sophie Pérusat

12

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Jean-Marc Tréluyer

13

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

CORIST-ANRS HC1 Study Group

15

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

language of work or name

0 references

publication date

9 May 2003

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Clinical Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

36

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

1295-1304

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Prevalence of Antibody to Hepatitis C Virus in Patients Infected with the Human Immunodeficiency Virus

1

1 reference

https://api.crossref.org/works/10.1086/374837

2 January 2024

Prevalence of hepatitis C virus antibodies among patients infected with human immunodeficiency virus

3

1 reference

https://api.crossref.org/works/10.1086/374837

2 January 2024

Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C. UK Haemophilia Centre Directors' Organisation

4

1 reference

https://api.crossref.org/works/10.1086/374837

2 January 2024

Ribavirin antagonizes the effect of azidothymidine on HIV replication

7

1 reference

https://api.crossref.org/works/10.1086/374837

2 January 2024

Effects of drugs on 2',3'-dideoxy-2',3'-didehydrothymidine phosphorylation in vitro

8

1 reference

https://api.crossref.org/works/10.1086/374837

2 January 2024

Drug interactions with zidovudine phosphorylation in vitro.

9

1 reference

https://api.crossref.org/works/10.1086/374837

2 January 2024

Effect of ribavirin on zidovudine efficacy and toxicity in vitro: a concentration-dependent interaction

10

1 reference

https://api.crossref.org/works/10.1086/374837

2 January 2024

Effects of drugs on 2',3'-dideoxy-2',3'-didehydrothymidine phosphorylation in vitro

11

1 reference

https://api.crossref.org/works/10.1086/374837

2 January 2024

Safety and efficacy of interferon-ribavirin combination therapy in HCV-HIV coinfected subjects: an early report

12

1 reference

https://api.crossref.org/works/10.1086/374837

2 January 2024

Effect of interferon and ribavirin on HIV viral load.

13

1 reference

https://api.crossref.org/works/10.1086/374837

2 January 2024

Once-daily combination therapy with emtricitabine, didanosine, and efavirenz in human immunodeficiency virus-infected patients

15

1 reference

https://api.crossref.org/works/10.1086/374837

2 January 2024

Direct determination of phosphorylated intracellular anabolites of stavudine (d4T) by liquid chromatography/tandem mass spectrometry.

17

1 reference

https://api.crossref.org/works/10.1086/374837

2 January 2024

Improved method for the simultaneous determination of d4T, 3TC and ddl intracellular phosphorylated anabolites in human peripheral-blood mononuclear cells using high-performance liquid chromatography/tandem mass spectrometry

18

1 reference

https://api.crossref.org/works/10.1086/374837

2 January 2024

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

19

1 reference

https://api.crossref.org/works/10.1086/374837

2 January 2024

Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I

20

1 reference

https://api.crossref.org/works/10.1086/374837

2 January 2024

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

21

1 reference

https://api.crossref.org/works/10.1086/374837

2 January 2024

Identifiers

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43048609&oldid=2043205049"